ArticleFrontiers in medicine2024
Redefining retinal vessel segmentation: empowering advanced fundus image analysis with the potential of GANs.
Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MedFusion-TransNet: multi-modal fusion via transformer for enhanced medical image segmentation.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal vessel segmentation is a critical task in fundus image analysis, providing essential insights for diagnosing various retinal diseases. In recent years, deep learning (DL) techniques, particularly Generative Adversarial Networks (GANs), have garnered significant attention for their potential to enhance medical image analysis. This paper presents a novel approach for retinal vessel segmentation by harnessing the capabilities of GANs. Our method, termed GANVesselNet, employs a specialized GAN architecture tailored to the intricacies of retinal vessel structures. In GANVesselNet, a dual-path network architecture is employed, featuring an Auto Encoder-Decoder (AED) pathway and a UNet-inspired pathway. This unique combination enables the network to efficiently capture multi-scale contextual information, improving the accuracy of vessel segmentation. Through extensive experimentation on publicly available retinal datasets, including STARE and DRIVE, GANVesselNet demonstrates remarkable performance compared to traditional methods and state-of-the-art deep learning approaches. The proposed GANVesselNet exhibits superior sensitivity (0.8174), specificity (0.9862), and accuracy (0.9827) in segmenting retinal vessels on the STARE dataset, and achieves commendable results on the DRIVE dataset with sensitivity (0.7834), specificity (0.9846), and accuracy (0.9709). Notably, GANVesselNet achieves remarkable performance on previously unseen data, underscoring its potential for real-world clinical applications. Furthermore, we present qualitative visualizations of the generated vessel segmentations, illustrating the network's proficiency in accurately delineating retinal vessels. In summary, this paper introduces GANVesselNet, a novel and powerful approach for retinal vessel segmentation. By capitalizing on the advanced capabilities of GANs and incorporating a tailored network architecture, GANVesselNet offers a quantum leap in retinal vessel segmentation accuracy, opening new avenues for enhanced fundus image analysis and improved clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.